PB PHASEBIO
Dead / Abandoned — Abandoned — no statement of use filed (as of 16 Oct 2023)
What this means for you
This application is over — abandoned 16 Oct 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88847647
- Mark type
- Design + words
- Filed
- 25 Mar 2020
- Published for opposition
- 21 Jul 2020
- Abandoned
- 16 Oct 2023
- Attorney of record
- Brendan J. Hughes
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for treating heart disease, heart conditions, hypertension, pulmonary hypertension, and other disorders of the cardiopulmonary system; pharmaceutical preparations for treating orphan diseases, namely, cystic fibrosis, Duchenne muscular dystrophy, Becker muscular dystrophy, achondroplasia, short bowel syndrome, hypoparathyroidism, systemic lupus erythematosus, insulin-like growth factor deficiency, growth hormone deficiency; pharmaceuticals comprising drugs based on recombinant Elastin-like polypeptides technology platform, namely, pharmaceuticals for treating heart disease, heart conditions, hypertension, pulmonary hypertension, other disorders of the cardiopulmonary system, and orphan diseases, namely, cystic fibrosis, Duchenne muscular dystrophy, Becker muscular dystrophy, achondroplasia, short bowel syndrome, hypoparathyroidism, systemic lupus erythematosus, insulin-like growth factor deficiency, growth hormone deficiency; pharmaceutical preparations consisting of reversal agents for counteracting the effects of platelet aggregation inhibitors
- Class 042 — Scientific and technological services: Medical and scientific research services, namely, medical research; medical and scientific research services all in the field of pharmaceuticals
Owner
- PhaseBio Pharmaceuticals, Inc., Malvern, PA, US
- PhaseBio Pharmaceuticals, Inc., Malvern, PA, US
Prosecution history
- 16 Oct 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 16 Oct 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 23 Mar 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Mar 2023 — SOU EXTENSION 5 GRANTED
- 10 Mar 2023 — SOU EXTENSION 5 FILED
- 22 Mar 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 10 Mar 2023 — SOU TEAS EXTENSION RECEIVED
- 07 Dec 2022 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 15 Sept 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Sept 2022 — SOU EXTENSION 4 GRANTED
- 13 Sept 2022 — SOU EXTENSION 4 FILED
- 13 Sept 2022 — SOU TEAS EXTENSION RECEIVED
- 18 Feb 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Feb 2022 — SOU EXTENSION 3 GRANTED
- 16 Feb 2022 — SOU EXTENSION 3 FILED